Central Command confirms disabling the ship following non-compliance warnings in the conflict zone.
Breaking News
Latest Posts
International Guests Put FREELANDER to the Test in Wuhu
The FREELANDER division of global automaker Chery concluded an intensive dynamic vehicle evaluation program in…
FREELANDER Showcases AI and Digital Technology to International Guests
Automotive innovator FREELANDER hosted an extensive technological showcase in Wuhu, China, presenting an international delegation…
Eskimoz Introduces an Integrated Approach to SEO, AI Search Visibility and Digital Acquisition
European digital acquisition agency Eskimoz unveiled a comprehensive search optimization methodology, integrating conventional technical search…
Iran State Media Claims Draft MOU with United States Includes Releasing $12 Billion in Frozen Assets
Tehran outlines conditions for reopening the Strait of Hormuz, though Washington pushes back on the specific text.
Israeli Military Coordinates Fresh Evacuation Demands For Seven Villages in Southern Lebanon
The orders follow deep incursions into Lebanese borders ahead of upcoming U.S.-brokered security talks.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 39
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 38
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 37
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 36
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 35
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 34
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.
Breakthrough Clinical Trial Maps Novel Pathways to Halt Parkinson’s Brain Progression 33
Scientists successfully block the GPNMB protein responsible for spreading toxic immune cells in neural tissues.